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Abstract 
BACKGROUND: Postmenopausis is a period that starts one year after the last menstruation. Late menopause, 
after 70 years, is called senile. 
AIM: To examine the correlation between endometrial thickness and the risk of endometrial malignancy in 
postmenopausal. 
MATERIAL AND METHODS: Prospective clinical study involving 120 postmenopausal patients treated at the 
University Clinic for Gynecology and Obstetrics – Skopje, divided into two groups: control and examination. The 
control group included 40 postmenopausal patients, hospitalised and operated due to urogenital pathology. The 
examined group consisted of 80 patients divided into three subgroups according to the ultrasound verified 
thickness of the endometrium: from 5-8 mm; > 8-11 mm and above 11 mm. A detailed history and intervention 
were taken in the patients from both groups, and the material was sent for histopathological analysis to determine 
eventual malignancy. 
RESULTS: The probability of endometrial malignancy significantly increased by 1.012 times in the group with a 
thickness of the endometrium from 5-8 mm, 1.769 times in the endometrial thickness group > 8-11 mm and 4.737-
fold in the group over 11 mm compared to the control group. 
CONCLUSION: In postmenopausal patients, the likelihood of endometrial cancer significantly increases with the 
thickness of the endometrium. 
 
 
 
 
 
 
 
Introduction 
 
Postmenopausal is a period that begins one 
year after the last menstrual period. In this period,a 
new source of oestrogens is estrone. The average 
age for menopause in developed countries is 51.4 
years [1]. It is divided into early and late menopause. 
Late menopause, after 70 years, is called senile. In 
10-15% of cases, postmenopausal bleeding is caused 
by endometrial cancer, and usually abnormal uterine 
bleeding is caused by endometrial polyps or atrophy 
[2]. The incidence of endometrial cancer in 
postmenopausal patients is 0.7% but increases in 
patients with additional risk factors [3]. In this period, 
abnormal uterine bleeding belongs to polyps, 
endometrial atrophy, endometrial hyperplasia, 
endometrial carcinoma, submucosal fibroid, hormone 
therapy, uterine or uterine infections, use of certain 
drugs [4], etc. 
According to FIGO, the International 
Federation of Gynecology and Oncology, the stages 
are subclassified into two pathological types. Type 1-
estrogen-dependent [5] in which in 30-80% of cases, 
the mutation of the PTEN gene is responsible for this 
type of malignant tumour. It occurs from complex 
atypical hyperplasia [6]; it is associated with estrogen 
stimulation and is not aggressive [7]. According to 
Kurmani's collaborators, this type of cancer is 
characterized by low malignancy, diagnosed in the 
early stage, has a superficial invasion of the 
myometrium and has high sensitivity and good 
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prognosis, with 85% five-year survival [8], [9]. Type 2-
neurosurgeon-dependent [5] endometrial cancer is 
poorly differentiated, with a deep myometrial invasion, 
including lymph nodes, low progestin sensitivity and 
58% five-year survival [8], [9]. It develops from an 
atrophic endometrium and is not associated with 
hormone stimulation [6] metastasizes and grows 
outside of the uterine hull [7]. Mutations of the P53 
gene occur in 50% of cases. 
Papillary serous and mesonephrom belongs 
in this group. This neoplasia is very aggressive. 
The purpose of the study was to investigate 
the predictive role of the thickness of the endometrium 
in the onset of endometrial malignancy in 
postmenopausal patients. 
 
 
Material and Methods 
 
This is a prospective clinical study, including 
120 postmenopausal patients treated at the University 
Clinic for Gynecology and Obstetrics - Skopje. 
Patients were divided into two groups: a control and 
examination group. The control group included 40 
postmenopausal patients, hospitalised and operated 
due to urogenital pathology, and ultrasonically 
detected endometrial thickness less than 5 mm. The 
examined group included 80 postmenopausal patients 
hospitalised due to endometrial bleeding with an 
ultrasound detection of an endometrial thickness 
greater or equal to 5 mm. According to the thickness 
of the endometrium, the examinees from the 
examined group were divided into three subgroups: a) 
subgroup 1 = 5-8 mm; b) subgroup 2 = 8-11 mm; and 
c) subgroup 3 => 11 mm. A detailed history and 
intervention were taken in the patients from both 
groups, and the received material was sent for 
histopathological analysis to determine eventual 
malignancy. 
The study excluded patients in generative 
reproductive age, patients who were not able to do 
fractional exploratory curettage, patients with a 
personal history of malignant disease (past or 
current), patients with a personal anemia for benign or 
malignant tumors of the ovary , breast cancer patients 
treated with tamoxifen , patients with any pelvic 
surgery due to other gynecological pathology. 
 
Statistical analysis 
The data during the survey were processed 
with the statistical package SPSS 20.0. The Pearson 
Chi-square homogeneity test was used to establish an 
association between certain attributive dichotomies of 
the two groups of respondents. The Shapiro-Wilk W 
test was used to determine the frequency distribution 
frequency of certain variables. To test the significance 
of the difference between two and more numerical 
variables with regular or irregular distribution of 
frequencies was the Studentov T-test for independent 
samples, the Mann Whitney U test and the Kruskal-
Wallis ANOVA test. A significance level of p < 0.05 
was used to determine the statistical significance. 
 
 
Results 
 
Characteristics of the sample 
In the investigated group of patients, the 
average age was 62.3 ± 7.7 years, and in control, it 
was 64.4 ± 7.5 years (Table 1). The tested difference 
between the two groups relative to age, p > 0.05, did 
not indicate a significant difference (Mann-Whitney U 
Test: Z = -1.3138; p = 0.1889). Patients from the 
investigated or control group have an average number 
of years in menopause 11.9 ± 6 v.s. 11.8 ± 4 years 
difference in significance between groups (Mann-
Whitney U Test: Z = -0.4397; p = 0.6601).  
Table 1: Descriptive analysis of the sample according to 
certain parameters and groups 
 
Group 
 
(Means
) 
 
Numbe
r 
Standard 
deviation 
(Std.Dev.) 
 
Minimum 
(Min) 
 
Maximu
m (Max) 
 
Median (IQR) 
Age 
Examination 62.33 80 7.68 49 84 61 (56-67) 
Control 64.37 40 7.51 52 79 65 (57.5-68) 
Years in menopause 
Examination 11.97 80 6.01 3 30 10 (7.5-15) 
Control 11.85 40 4.03 5 18 11.5 (8-15) 
BMI 
Examination 29.46 80 5.42 14.9 42.7 29.7 (26-32.3) 
Control 28.66 40 3.85 21.8 41.4 28.2 (26.1-30.3) 
 
In the whole sample, the majority of the 
respondents were married 115 (95.8%), 1 (0.8%) 
were single, and 4 (3.3%) divorced (Table 1). For p > 
0.05, no significant association was found between 
the group and the marital status of the subjects 
(Fisher-Freeman-Halton exact test: p = 0.9999). 
Both the examination and the control group 
are dominated by the majority of respondents who are 
non-smokers, and consequently, 52 (65%) v.s. 30 
(75%) (Table 1). For p > 0.05, there is no statistically 
significant association between the group to which the 
examinees belong and the smoking status (Pearson 
Chi-square test = 0.2323; df = 1; p = 0.2669). 
Patients in the examined group had an 
average BMI of 29.5 ± 5.4, and those of the control 
28.7 ± 3.8 without a significant difference between the 
two groups compared to this parameter (Student's t-
test for independent sample = 0.8346; df = 118; p = 
0.4056) (Table 1). 
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Endometrial analysis 
The average thickness of the endometrium in 
the examined group was 10.8 ± 5.6 mm with a 
minimum thickness of 6mm and a maximum thickness 
of 32mm while in the control group it was 2.7 ± 0.8 
mm with a minimum thickness of 1mm and a 
maximum thickness of 4.5 mm (Table 2). According to 
the median analysis, 50% of the patients in the control 
or examination group had endometrium thickness 
greater than the corresponding IQR = 2.8 mm (2-3) 
v.s. IQR = 9mm (7-12). The analysis, for p < 0.05, 
indicated a significant difference between the 
examinees of both groups in terms of endometrial 
thickness (Mann-Whitney U Test: Z = 8.907235 p = 
0.00001) in favour of a significantly thicker 
endometrium in the assay group. 
Table 2: Analysis of the thickness of the endometrium (mm) in 
the control and examination group 
Group N  ± sd Minimum (min) Maximum (max) Mediana (iqr) 
Examination 80 10.8 ± 5.6 6 32 9 (7 – 12) 
Control 40 2.7 ± 0.8 1 4.5 2.8 (2 – 3) 
Mann-Whitney U Test: Z = 8.907235; p = 0.00001; ** Significant for p < 0.05. 
 
According to the results of the ultrasound-
ultrasound measurement of the thickness of the 
endometrium, the examination group (N = 80 patients) 
was divided into three subgroups: (a) 5-8 mm with a 
total of 36 (45%) patients; (b) < 8-11 mm with a total 
of 17 (21.25%) patients; and (c) < 11 mm with a total 
of 27 (33.75%) patients (Table 3). 
Table 3: Division in subgroups of the examination group by 
endometrial thickness 
Subgroups by the thickness of the endometrium (mm) Number % 
5-8 36 45 
> 8-11 17 21.2 
> 11 27 33.7 
Total value 80 100% 
 
In the control group, the average thickness of 
the endometrium was 2.7 ± 0.8 mm, with a minimum 
thickness of 1mm and a maximum thickness of 4.5 
mm. In the first subgroup with thickness of 
endometrium 5-8mm, the average thickness of the 
endometrium was 6.9 ± 0.9 mm with a minimum of 6.0 
mm and a maximum of 8.0 mm. According to the 
media analysis, 50% of patients in this subgroup have 
an endometrial thickness greater than IQR = 7 mm (5-
8 mm). In the second subgroup with an endometrial 
thickness of 8.0-11.0 mm, the average thickness of 
the endometrium was 9.4 ± 0.5 mm with a minimum of 
9mm and a maximum thickness of 10mm. According 
to the analysis of the media, 50% of patients in this 
subgroup have an endometrial thickness greater than 
IQR = 9 mm (9.0-10.0 mm). In the third subgroup with 
a thickness of endometrium > 11 mm, the average 
endometrium thickness was 16.8 ± 5.8 mm with a 
minimum of 11 mm and a maximum of 32 mm. 
According to the median analysis, 50% of patients in 
this subgroup had an endometrial thickness greater 
than IQR = 14 mm (12.0 -22.0 mm) (Table 3). 
Table 4: Thickness of endometrium (mm) in subgroups of the 
examination group 
 
Subgroups 
The thickness 
of the 
endometrium 
(mm) 
 
N 
 
SD 
 
Minimum 
 
Maximum 
 
Median (IQR) 
Subgroup 1 5 – 8 36 6.90 ± 0.88 6 8 7 (5 – 8) 
Subgroup 2 > 8 – 11 17 9.40 ± 0.49 9 10 9 (9 – 10) 
Subgroup 3 > 11 27 16.82 ± 5.82 11 32 14 (12 – 22) 
 
For p < 0.05, a significant difference was 
found between the three subgroups of the examinated 
group compared to the thickness of the endometrium 
(Kruskal-Wallis ANOVA: H = 68.967; p = 0.00001). 
The individual subgroup analysis, for p < 0.05, 
indicated a significant difference between the first and 
second , first and third vs. the second and third 
subunits for consequently Mann-Whitney U Test: Z = -
5.831; p = 0.00001 vs. Mann-Whitney U Test: Z = -
6,750; p = 0.00001 vs. Mann-Whitney U Test: Z = -
5.532; p = 0.00001 (Table 4). 
Table 5: Binary logistic regression analysis of the 
predictive role of endometrial thickness for 
prediction of endometrial malignancy 
 
Variable 
 
 
B 
 
 
S.E. 
 
 
Wald 
 
 
Df 
 
 
Sig. 
 
 
Exp(B) 
 
95% C.I.for 
EXP(B) 
Lower Upper 
The thickness of endometrium about unit thickness of endometrium 
endometrium 
(mm) 
0.164 0.052 10.073 1 0.002* 1.178 1.065 1.304 
Endometrium thickness - reference category / < 5mm 
5 mm -8 mm 1.897 1.381 2.864 1 0.049* 1.012 1.014 3.549 
>8 mm - 11 mm 2.377 1.164 4.167 1 0.041* 1.769 1.099 5.488 
>11 mm 2.690 1.098 6.001 1 0.014* 4.737 1.712 12.840 
* Significant for p < 0.05. 
 
The thickness of the endometrium is a 
significant predictor of endometrial malignancy (p < 
0.05). With each millimeter an increase in 
endometrium, the likelihood of endometrial 
malignancy increases significantly by 1,178 [p = 
0.002, 95% CI = 1.065-1.304] times. Compared to 
patients with a thickness of endometrium < 5 mm, 
binary logistic regression indicated that the probability 
of endometrial cancer was for: a) 1.012 [p = 0.049, 
95% CI = 1.014-3.549] times greater in endometrial 
thickness of 5-8 mm; b) 1.769 [p = 0.041, 95% CI = 
1.099-5.488] times greater in endometrial thickness > 
8-11 mm; and c) 4.737 [p = 0.014, 95% CI = 1.712-
12.840] times greater in patients with an endometrial 
thickness of > 11 mm (Table 5). 
 
 
Discussion 
 
The results of this study showed that with an 
increase in unit endometrium, the likelihood of 
malignancy increased by 1,178. Namely, an increase 
in the thickness of the endometrium by 1 mm relative 
to the control group significantly increases the 
likelihood of endometrial malignancy in patients with 
endometrial thickness from 5-8 mm in 1,012 times, in 
Clinical Science 
_______________________________________________________________________________________________________________________________ 
 
_______________________________________________________________________________________________________________________________ 
2266                                                                                                                                                                                              https://www.id-press.eu/mjms/index 
 
those with an endometrium thickness of 8-11 mm in 
1,769 times, while in patients with endometrial 
thickness > 11 mm, the likelihood of endometrial 
cancer is greatest and increases by 4,737 times in 
relation to control. The results of this study correlate 
with the relevant literature concerned. 
Thus, in the study of Smith-Bindman et al. in 
which correlation between endometrial thickness and 
endometrial cancer risk was examined, a 6.7% risk of 
endometrial malignancy was found in patients with an 
endometrial thickness of over 11 mm and a 0.002% 
risk of endometrial thickness below 11 mm (10). 
In conclusion, the thickness of the 
endometrium is a significant predictor of endometrial 
malignancy. With each millimetre, an increase in the 
endometrium significantly increases the likelihood of 
endometrial malignancy for: 
-Enlargement for a unit of the endometrium, 
the risk of endometrial malignancy increases by 1.178 
times. 
-1.012 times [p = 0.002, 95% CI = 1.065-
1.304] in the group with a thickness of the 
endometrium of 5-8 mm relative to the control. 
-1.769 times [p = 0.041, 95% CI = 1.099-
5.488] in the endometrial thickness group of 8-11 mm 
in terms of control. 
-4.737 times [p = 0.014, 95% CI = 1.712-
12.840] in the group with an endometrial thickness of 
over 11 mm relative to the control group.  
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